UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
|
|||
FORM
8-K
|
|||
CURRENT
REPORT
|
|||
Pursuant
to Section 13 OR 15(d) of the Securities Exchange Act of 1934
|
|||
Date
of Report (Date of earliest event reported): May 10,
2010
|
|||
NexMed,
Inc.
|
|||
(Exact
name of registrant as specified in its charter)
|
|||
Nevada
|
0-22245
|
87-0449967
|
|
(State
or other jurisdiction
of
incorporation)
|
(Commission
File
Number)
|
(I.R.S.
Employer
Identification
No.)
|
|
6330
Nancy Ridge Drive, Suite 103, San Diego, California
|
92121
|
||
(Address
of principal executive offices)
|
(Zip
Code)
|
||
Registrant’s
telephone number, including area code (858)
222-8041
|
|||
(Former
name or former address, if changed since last report.)
|
|||
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
|
|||
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
||
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
||
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
||
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13a-4(c))
|
Item
8.01.
|
Other
Events
|
NEXMED,
INC.
|
|||
By:
|
/s/
Mark Westgate
|
||
Name:
Mark Westgate
|
|||
Title:
Vice President and Chief Financial Officer
|
|||